Effect of Sotrovimab on Hospitalization or Death Among High-risk Patients With Mild to Moderate COVID-19A Randomized Clinical Trial

Posted on by

JAMA
April 5, 2022, Vol 327, No. 13, Pages 1209-1300
https://jamanetwork.com/journals/jama/currentissue

 

Original Investigation
Effect of Sotrovimab on Hospitalization or Death Among High-risk Patients With Mild to Moderate COVID-19A Randomized Clinical Trial
Anil Gupta, MD; Yaneicy Gonzalez-Rojas, MD; Erick Juarez, MD; et al.
free access has active quiz
JAMA. 2022;327(13):1236-1246. doi:10.1001/jama.2022.2832
This randomized clinical trial compares the efficacy and adverse events of sotrovimab vs placebo in preventing progression of mild to moderate COVID-19 to severe disease.

Effect of Antiplatelet Therapy on Survival and Organ Support–Free Days in Critically Ill Patients With COVID-19A Randomized Clinical Trial

Posted on by

JAMA
April 5, 2022, Vol 327, No. 13, Pages 1209-1300
https://jamanetwork.com/journals/jama/currentissue

 

Caring for the Critically Ill Patient
Effect of Antiplatelet Therapy on Survival and Organ Support–Free Days in Critically Ill Patients With COVID-19A Randomized Clinical Trial
REMAP-CAP Writing Committee for the REMAP-CAP Investigators
free access has active quiz
JAMA. 2022;327(13):1247-1259. doi:10.1001/jama.2022.2910
This randomized clinical trial assesses the effect of treatment with an antiplatelet agent vs no antiplatelet therapy on days alive and free of intensive care unit respiratory or cardiovascular organ support within 21 days among patients critically ill with COVID-19.

Association Between 2-Dose vs 3-Dose Hepatitis B Vaccine and Acute Myocardial Infarction

Posted on by

JAMA
April 5, 2022, Vol 327, No. 13, Pages 1209-1300
https://jamanetwork.com/journals/jama/currentissue

 

Association Between 2-Dose vs 3-Dose Hepatitis B Vaccine and Acute Myocardial Infarction
Katia Bruxvoort, PhD; Jeff Slezak, MS; Lei Qian, PhD; et al.
free access
JAMA. 2022;327(13):1260-1268. doi:10.1001/jama.2022.2540
This large prospective cohort study compares the rates of acute myocardial infarction between recipients of a 2-dose hepatitis B vaccine and recipients of a 3-dose hepatitis B vaccine.

Estimates of SARS-CoV-2 Omicron Variant Severity in Ontario, Canada

Posted on by

JAMA
April 5, 2022, Vol 327, No. 13, Pages 1209-1300
https://jamanetwork.com/journals/jama/currentissue

 

Research Letter
Estimates of SARS-CoV-2 Omicron Variant Severity in Ontario, Canada
Ana Cecilia Ulloa, MPH; Sarah A. Buchan, PhD; Nick Daneman, MD, MSc; et al.
free access has active quiz has audio
JAMA. 2022;327(13):1286-1288. doi:10.1001/jama.2022.2274
This study examines hospitalizations and deaths associated with the SARS-CoV-2 Omicron variant compared with matched patients infected with the Delta variant.

Expanding Efforts and Support to Respond to the HIV and COVID-19 Intersecting Pandemics

Posted on by

JAMA
April 5, 2022, Vol 327, No. 13, Pages 1209-1300
https://jamanetwork.com/journals/jama/currentissue

 

Viewpoint
Expanding Efforts and Support to Respond to the HIV and COVID-19 Intersecting Pandemics
Lawrence Corey, MD; Russell Corbett-Detig, PhD; Chris Beyrer, MD, MPH
free access
JAMA. 2022;327(13):1227-1228. doi:10.1001/jama.2022.3517
This Viewpoint discusses the generation of SARS-CoV-2 variants of concern globally and the need for increased access to COVID-19 vaccination in Africa, particularly for people living with HIV and for households and people living in densely populated communities.

The potential of mitochondrial genome engineering

Posted on by

Nature Reviews Genetics
Volume 23 Issue 4, April 2022
https://www.nature.com/nrg/volumes/23/issues/4

 

Review Article | 02 December 2021
The potential of mitochondrial genome engineering
The authors review the field of mammalian mitochondrial genome engineering, culminating in the recent development of mitochondrially targeted programmable nucleases and base editors. They describe research that led to the development of animal models of mitochondrial disease, as well as the potential for translating these approaches to the clinic.
Pedro Silva-Pinheiro, Michal Minczuk

Lessons from Long COVID: working with patients to design better research

Posted on by

Nature Reviews Immunology
Volume 22 Issue 4, April 2022
https://www.nature.com/nri/volumes/22/issues/4

 

Comment | 15 February 2022
Lessons from Long COVID: working with patients to design better research
In this Comment article, Nisreen Alwan discusses what her experience as both a public health academic and a person living with Long COVID has taught her about the importance of including those with lived experience of a condition in setting the research agenda.
Nisreen A. Alwan

Vaccine safety in an era of novel vaccines: a proposed research agenda

Posted on by

Nature Reviews Immunology
Volume 22 Issue 4, April 2022
https://www.nature.com/nri/volumes/22/issues/4

 

Collection: COVID-19 Watch
Comment | 23 February 2022
Vaccine safety in an era of novel vaccines: a proposed research agenda
In this Comment article, Gregory Poland and Richard Kennedy outline the importance of continued funding and infrastructure support for research into vaccine safety to inform public health decisions and increase public trust in new vaccine technologies.
Gregory A. Poland
Richard B. Kennedy

Mucosal vaccines — fortifying the frontiers

Posted on by

Nature Reviews Immunology
Volume 22 Issue 4, April 2022
https://www.nature.com/nri/volumes/22/issues/4

 

Review Article | 26 July 2021
Mucosal vaccines — fortifying the frontiers
Here, Ed Lavelle and Ross Ward discuss the unique aspects of mucosal immunity that must be considered when developing effective mucosal vaccines. The authors highlight the key immune cell populations that are targeted by mucosal vaccination strategies and explain how innovative adjuvant and delivery approaches should lead to new vaccines for infectious diseases and cancers.
Ed C. Lavelle
Ross W. Ward

Identification of neoantigens for individualized therapeutic cancer vaccines

Posted on by

Nature Reviews Drug Discovery
Volume 21 Issue 4, April 2022
https://www.nature.com/nrd/volumes/21/issues/4

 

Review Article | 01 February 2022
Identification of neoantigens for individualized therapeutic cancer vaccines
Mutations in cancer cells can generate tumour-specific neoepitopes, which are attractive targets for anticancer vaccines. This Review discusses the mechanisms of neoantigen T cell recognition and computational approaches to predict which neoantigens might confer proficient antitumour immunity in a given clinical context.
Franziska Lang, Barbara Schrörs, Ugur Sahin

Population Immunity and Covid-19 Severity with Omicron Variant in South Africa

Posted on by

New England Journal of Medicine
April 7, 2022 Vol. 386 No. 14
https://www.nejm.org/toc/nejm/medical-journal

 

Original Articles
Population Immunity and Covid-19 Severity with Omicron Variant in South Africa S.A. Madhi and Others
Widespread underlying SARS-CoV-2 seropositivity was observed in Gauteng before the omicron-dominant wave of Covid-19. Epidemiologic data showed a decoupling of hospitalizations and deaths from infections while omicron was circulating.

Prenatal influenza vaccination and allergic and autoimmune diseases in childhood: A longitudinal, population-based linked cohort study

Posted on by

PLoS Medicine
http://www.plosmedicine.org/
(Accessed 09 Apr 2022)

 

Prenatal influenza vaccination and allergic and autoimmune diseases in childhood: A longitudinal, population-based linked cohort study
Damien Foo, Mohinder Sarna, Gavin Pereira, Hannah C. Moore, Annette K. Regan
Research Article | published 05 Apr 2022 PLOS Medicine
https://doi.org/10.1371/journal.pmed.1003963

Awareness, attitudes and acceptability of the HPV vaccine among female university students in Morocco

Posted on by

PLoS One
http://www.plosone.org/
[Accessed 09 Apr 2022]

 

Awareness, attitudes and acceptability of the HPV vaccine among female university students in Morocco
A. Yacouti, N. Elkhoudri, A. El got, A. Benider, F. Hadrya, R. Baddou, A. Forster, M. Mouallif
Research Article | published 08 Apr 2022 PLOS ONE
https://doi.org/10.1371/journal.pone.0266081

COVID-19 vaccine acceptance, hesitancy, and associated factors among medical students in Sudan

Posted on by

PLoS One
http://www.plosone.org/
[Accessed 09 Apr 2022]

 

COVID-19 vaccine acceptance, hesitancy, and associated factors among medical students in Sudan
Saud Mohammed Raja, Murwan Eissa Osman, Abdelmageed Osman Musa, Asim Abdelmoneim Hussien, Kabirat Yusuf
Research Article | published 07 Apr 2022 PLOS ONE
https://doi.org/10.1371/journal.pone.0266670

The COVID-19 Vaccine: Trust, doubt, and hope for a future beyond the pandemic in Germany

Posted on by

PLoS One
http://www.plosone.org/
[Accessed 09 Apr 2022]

 

The COVID-19 Vaccine: Trust, doubt, and hope for a future beyond the pandemic in Germany
Amelia Fiske, Franziska Schönweitz, Johanna Eichinger, Bettina Zimmermann, Nora Hangel, Anna Sierawska, Stuart McLennan, Alena Buyx
Research Article | published 07 Apr 2022 PLOS ONE
https://doi.org/10.1371/journal.pone.0266659

Knowledge, attitude, and practice of seasonal influenza and influenza vaccine immunization among people visiting primary healthcare centers in Riyadh, Saudi Arabia

Posted on by

PLoS One
http://www.plosone.org/
[Accessed 09 Apr 2022]

 

Knowledge, attitude, and practice of seasonal influenza and influenza vaccine immunization among people visiting primary healthcare centers in Riyadh, Saudi Arabia
Norah Alhatim, Ahmad M. Al-Bashaireh, Ola Alqudah
Research Article | published 04 Apr 2022 PLOS ONE
https://doi.org/10.1371/journal.pone.0266440

A single-shot vaccine approach for the universal influenza A vaccine candidate M2e

Posted on by

PNAS – Proceedings of the National Academy of Sciences of the United States
March 29, 2022 | vol. 119 | no. 13
https://www.pnas.org/toc/pnas/119/13

 

Research Article
March 23, 2022
A single-shot vaccine approach for the universal influenza A vaccine candidate M2e
Influenza, commonly referred to as “flu,” is a major global public health concern and a huge economic burden to societies. Current influenza vaccines need to be updated annually to match circulating strains, resulting in low take-up rates and poor …
Ranmali Kavishna, Tha Yang Kang, […] Sylvie Alonso

The Serbian COVID-19 Stress Scale and vaccine acceptance: is there a place for COVID-19-related distress in explaining attitudes towards vaccination?

Posted on by

Public Health
Volume 205 Pages e1-e30, 1-216 (April 2022)
https://www.sciencedirect.com/journal/public-health/vol/205/suppl/C

 

Research article Full text access
The Serbian COVID-19 Stress Scale and vaccine acceptance: is there a place for COVID-19-related distress in explaining attitudes towards vaccination?
L. Mihić, Z. Terzić-Šupić, J. Todorović, N.P. Marić
Pages 37-42

Building the concept for WHO Evidence Considerations for Vaccine Policy (ECVP): Tuberculosis vaccines intended for adults and adolescents as a test case

Posted on by

Vaccine
Volume 40, Issue 12 Pages 1681-1912 (15 March 2022)
https://www.sciencedirect.com/journal/vaccine/vol/40/issue/12

 

Conference info Open access
Building the concept for WHO Evidence Considerations for Vaccine Policy (ECVP): Tuberculosis vaccines intended for adults and adolescents as a test case
Sonali Kochhar, Draurio Barreira, Pauline Beattie, Marco Cavaleri, … Birgitte Giersing
Pages 1681-1690

Projecting the cost of introducing typhoid conjugate vaccine (TCV) in the national immunization program in Malawi using a standardized costing framework

Posted on by

Vaccine
Volume 40, Issue 12 Pages 1681-1912 (15 March 2022)
https://www.sciencedirect.com/journal/vaccine/vol/40/issue/12

 

Research article Open access
Projecting the cost of introducing typhoid conjugate vaccine (TCV) in the national immunization program in Malawi using a standardized costing framework
Frédéric Debellut, Rouden Mkisi, Vincent Masoo, Mike Chisema, … Clint Pecenka
Pages 1741-1746

Impact of the COVID-19 pandemic on routine immunization coverage in children under 2 years old in Ontario, Canada: A retrospective cohort study

Posted on by

Vaccine
Volume 40, Issue 12 Pages 1681-1912 (15 March 2022)
https://www.sciencedirect.com/journal/vaccine/vol/40/issue/12

 

Research article Open access
Impact of the COVID-19 pandemic on routine immunization coverage in children under 2 years old in Ontario, Canada: A retrospective cohort study
Catherine Ji, Pierre-Philippe Piché-Renaud, Jemisha Apajee, Ellen Stephenson, … Karen Tu
Pages 1790-1798

Exploring the attitudes, concerns, and knowledge regarding COVID-19 vaccine by the parents of children with rheumatic disease: Cross-sectional online survey

Posted on by

Vaccine
Volume 40, Issue 12 Pages 1681-1912 (15 March 2022)
https://www.sciencedirect.com/journal/vaccine/vol/40/issue/12

 

Research article Full text access
Exploring the attitudes, concerns, and knowledge regarding COVID-19 vaccine by the parents of children with rheumatic disease: Cross-sectional online survey
Özlem Akgün, Gülşah Kavrul Kayaalp, Fatma Gül Demirkan, Figen Çakmak, … Nuray Aktay Ayaz
Pages 1829-1836

The role of perceived social norms in college student vaccine hesitancy: Implications for COVID-19 prevention strategies

Posted on by

Vaccine
Volume 40, Issue 12 Pages 1681-1912 (15 March 2022)
https://www.sciencedirect.com/journal/vaccine/vol/40/issue/12

 

Research article Full text access
The role of perceived social norms in college student vaccine hesitancy: Implications for COVID-19 prevention strategies
Anna E. Jaffe, Scott Graupensperger, Jessica A. Blayney, Jennifer C. Duckworth, Cynthia A. Stappenbeck
Pages 1888-1895

Conspiracy beliefs and distrust of science predicts reluctance of vaccine uptake of politically right-wing citizens

Posted on by

Vaccine
Volume 40, Issue 12 Pages 1681-1912 (15 March 2022)
https://www.sciencedirect.com/journal/vaccine/vol/40/issue/12

 

Research article Full text access
Conspiracy beliefs and distrust of science predicts reluctance of vaccine uptake of politically right-wing citizens
T. Winter, B.C. Riordan, D. Scarf, P.E. Jose
Pages 1896-1903

Pre-Print Servers

Posted on by

Pre-Print Servers

 

Gates Open Research
https://gatesopenresearch.org/browse/articles

Open Letter metrics AWAITING PEER REVIEW
Enabling evidence to tackle everyday diseases to mitigate another pandemic [version 1; peer review: awaiting peer review]
Trudie Lang
Peer Reviewers Invited
Funders
Bill and Melinda Gates Foundation
Wellcome
PUBLISHED 07 Apr 2022

Research Article metrics
Revised
Asymptomatic COVID-19 in the elderly: dementia and viral clearance as risk factors for disease progression. [version 2; peer review: 2 approved]
Ignacio Esteban, Georgina Bergero, Camila Alves, Micaela Bronstein, Valeria Ziegler, Cristian Wood, Mauricio T. Caballero, Diego Wappner, Romina Libster, Gonzalo Perez Marc, Fernando P. Polack
Peer Reviewers Carlota Dobaño; Kirsten E. Wiens
Funder
Bill and Melinda Gates Foundation
LATEST VERSION PUBLISHED 04 Apr 2022

 

medRxiv
https://www.medrxiv.org/content/about-medrxiv
medRxiv is a free online archive and distribution server for complete but unpublished manuscripts (preprints) in the medical, clinical, and related health sciences. Preprints are preliminary reports of work that have not been certified by peer review. They should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information. medRxiv is for the distribution of preprints – complete but unpublished manuscripts – that describe human health research conducted, analyzed, and interpreted according to scientific principles…

Reports of myocarditis and pericarditis following mRNA COVID-19 vaccines: A systematic review of spontaneously reported data from the UK, Europe, and the US and of the literature
Samantha Lane, Alison Yeomans, Saad Shakir
medRxiv 2021.09.09.21263342; doi: https://doi.org/10.1101/2021.09.09.21263342 Revision

Vaccine effectiveness of BNT162b2 against Omicron and Delta outcomes in adolescents
Sarah A. Buchan, Lena Nguyen, Sarah E. Wilson, Sophie A. Kitchen, Jeffrey C. Kwong
medRxiv 2022.04.07.22273319; doi: https://doi.org/10.1101/2022.04.07.22273319

COVID-19: Knowledge, Perception of Risk, Preparedness and Vaccine Acceptability among Healthcare Workers in Kenya
Hafso Mohamed Abdulle, Moses Muia Masika, Julius Otieno Oyugi
medRxiv 2021.10.19.21264712; doi: https://doi.org/10.1101/2021.10.19.21264712 Revision

COVID-19 vaccination coverage by company size and the effects of socioeconomic factors and workplace vaccination in Japan: a cohort study
Koji Mori, Takahiro Mori, Tomohisa Nagata, Hajime Ando, Ayako Hino, Seiichiro Tateishi, Mayumi Tsuji, Keiji Muramatsu, Yoshihisa Fujino, the CORoNa Work Project
medRxiv 2022.03.30.22273203; doi: https://doi.org/10.1101/2022.03.30.22273203 Revision

Trans-border transfer of human biological materials in collaborative biobanking research: Perceptions and experiences of researchers in Uganda
Erisa Sabakaki Mwaka, Ian Guyton Munabi
medRxiv 2022.04.01.22273073; doi: https://doi.org/10.1101/2022.04.01.22273073

Effectiveness of a nation-wide COVID-19 vaccination program in Mexico
Omar Yaxmehen Bello-Chavolla, Neftali Eduardo Antonio-Villa, Sergio Iván Valdés-Ferrer, Carlos A. Fermín-Martínez, Luisa Fernández-Chirino, Daniel Ramírez-García, Javier Mancilla-Galindo, Ashuin Kammar-García, José Alberto Ávila-Funes, Clemente Humberto Zúñiga-Gil, Miguel García-Grimshaw, Santa Elizabeth Ceballos-Liceaga, Guillermo Carbajal-Sandoval, José Antonio Montes-González, Christian Arturo Zaragoza-Jiménez, Gabriel García-Rodríguez, Ricardo Cortés-Alcalá, Gustavo Reyes-Terán, Hugo López-Gatell, Luis Miguel Gutiérrez-Robledo
medRxiv 2022.04.04.22273330; doi: https://doi.org/10.1101/2022.04.04.22273330

The trustworthiness and impact of trial preprints for COVID-19 decision-making: A methodological study
Dena Zeraatkar, Tyler Pitre, Gareth Leung, Ellen Cusano, Arnav Agarwal, Faran Khalid, Zaira Escamilla, Matthew Cooper, Maryam Ghadimi, Ying Wang, Francisca Verdugo, Gabriel Rada, Elena Kum, Anila Qasim, Jessica J Bartoszko, Reed Siemieniuk, Chirag J. Patel, Gordon Guyatt, Romina Brignardello-Petersen
medRxiv 2022.04.04.22273372; doi: https://doi.org/10.1101/2022.04.04.22273372

Wastewater sequencing uncovers early, cryptic SARS-CoV-2 variant transmission
Smruthi Karthikeyan, Joshua I Levy, Peter De Hoff, Greg Humphrey, Amanda Birmingham, Kristen Jepsen, Sawyer Farmer, Helena M. Tubb, Tommy Valles, Caitlin E Tribelhorn, Rebecca Tsai, Stefan Aigner, Shashank Sathe, Niema Moshiri, Benjamin Henson, Adam M. Mark, Abbas Hakim, Nathan A Baer, Tom Barber, Pedro Belda-Ferre, Marisol Chacón, Willi Cheung, Evelyn S Cresini, Emily R Eisner, Alma L Lastrella, Elijah S Lawrence, Clarisse A Marotz, Toan T Ngo, Tyler Ostrander, Ashley Plascencia, Rodolfo A Salido, Phoebe Seaver, Elizabeth W Smoot, Daniel McDonald, Robert M Neuhard, Angela L Scioscia, Alysson M. Satterlund, Elizabeth H Simmons, Dismas B. Abelman, David Brenner, Judith C. Bruner, Anne Buckley, Michael Ellison, Jeffrey Gattas, Steven L. Gonias, Matt Hale, Faith Hawkins, Lydia Ikeda, Hemlata Jhaveri, Ted Johnson, Vince Kellen, Brendan Kremer, Gary Matthews, Ronald W. McLawhon, Pierre Ouillet, Daniel Park, Allorah Pradenas, Sharon Reed, Lindsay Riggs, Alison Sanders, Bradley Sollenberger, Angela Song, Benjamin White, Terri Winbush, Christine M Aceves, Catelyn Anderson, Karthik Gangavarapu, Emory Hufbauer, Ezra Kurzban, Justin Lee, Nathaniel L Matteson, Edyth Parker, Sarah A Perkins, Karthik S Ramesh, Refugio Robles-Sikisaka, Madison A Schwab, Emily Spencer, Shirlee Wohl, Laura Nicholson, Ian H Mchardy, David P Dimmock, Charlotte A Hobbs, Omid Bakhtar, Aaron Harding, Art Mendoza, Alexandre Bolze, David Becker, Elizabeth T Cirulli, Magnus Isaksson, Kelly M Schiabor Barrett, Nicole L Washington, John D Malone, Ashleigh Murphy Schafer, Nikos Gurfield, Sarah Stous, Rebecca Fielding-Miller, Richard S. Garfein, Tommi Gaines, Cheryl Anderson, Natasha K. Martin, Robert Schooley, Brett Austin, Duncan R. MacCannell, Stephen F Kingsmore, William Lee, Seema Shah, Eric McDonald, Alexander T. Yu, Mark Zeller, Kathleen M Fisch, Christopher Longhurst, Patty Maysent, David Pride, Pradeep K. Khosla, Louise C. Laurent, Gene W Yeo, Kristian G Andersen, Rob Knight
medRxiv 2021.12.21.21268143; doi: https://doi.org/10.1101/2021.12.21.21268143 Revision

Wellcome Open Research [to 09 Apr 2022]
https://wellcomeopenresearch.org/browse/articles
[Accessed 09 Apr 2022]

Wellcome Open Research provides all Wellcome researchers with a place to rapidly publish any results they think are worth sharing. All articles benefit from rapid publication, transparent peer review and editorial guidance on making all source data openly available.

Research Article metrics
Revised
A survey to gather perspectives of DBT/Wellcome Trust India Alliance-funded researchers on public engagement with science [version 2; peer review: 2 approved with reservations]
Sarah Iqbal, Banya Kar
Peer Reviewers Marina Joubert; Mary Chambers and Han Dong Thai Tran
Funder
DBT/Wellcome Trust India Alliance
LATEST VERSION PUBLISHED 08 Apr 2022

Systematic Review metrics
Revised
Incentivising research data sharing: a scoping review [version 2; peer review: 3 approved]
Helen Buckley Woods, Stephen Pinfield
Peer Reviewers Cameron Neylon; Carol Tenopir; Birgit Schmidt
Funder
Wellcome
LATEST VERSION PUBLISHED 06 Apr 2022

Study Protocol metrics
Revised
“AMR Dialogues”: a public engagement initiative to shape policies and solutions on antimicrobial resistance (AMR) in Thailand [version 2; peer review: 1 approved, 1 approved with reservations]
Tassawan Poomchaichote, Anne Osterrieder, Ravikanya Prapharsavat, Bhensri Naemiratch, Supanat Ruangkajorn, Chaiwat Thirapantu, Karnjariya Sukrung, Niyada Kiatying-Angsulee, Nithima Sumpradit, Sirima Punnin, Direk Limmathurotsakul, Phaik Yeong Cheah
Peer Reviewers David Kaawa-Mafigiri; Papreen Nahar
Funder
Wellcome Trust
LATEST VERSION PUBLISHED 07 Apr 2022

Think Tanks

Posted on by

Think Tanks
 
 
Brookings
http://www.brookings.edu/
Accessed 09 Apr 2022
[No new digest content identified]
 
 
Center for Global Development [to 09 Apr 2022]
https://www.cgdev.org/
Research [Selected]
CGD NOTES
Policy Actions for the US Government to Accelerate Access to Oral Antivirals for COVID-19 in Low- and Middle-Income Countries
Javier Guzman et al.
April 07, 2022
While oral antivirals are not a substitute for vaccination, they are key to preventing severe illness, saving lives, and preserving health systems. Vaccination rates continue to be low in low-income countries; only 14 percent of the population in low-income countries has received one dose of the vac…
 
 
Chatham House [to 09 Apr 2022]
https://www.chathamhouse.org/
Accessed 09 Apr 2022
[No new digest content identified]

 
 
CSIS
https://www.csis.org/
Accessed 09 Apr 2022
[No new digest content identified]

 
 

Kaiser Family Foundation
https://www.kff.org/search/?post_type=press-release
Accessed 09 Apr 2022
April 8, 2022 News Release
Ending COVID-19 Emergency Declarations Will Bring an End to Flexibilities that Aided Patients, Providers, Insurers, and Public Programs in Responding to the Pandemic
When the federal government ends COVID-19 emergency declarations that were declared in the early days of the pandemic, it will bring to a close several changes that were enacted temporarily to enable the U.S. health care system to better deal with the crisis. A new KFF resource details a number…

April 6, 2022 News Release
As the COVID-19 Pandemic Enters the Third Year Most Adults Say They Have Not Fully Returned to Pre-Pandemic ‘Normal’
People of Color, Lower Income Adults, and Those With Chronic Conditions Are More Vigilant About COVID-19 Precautions Like Masking, and Want Others to Continue Them as Well The Public Is Divided About Public Transportation Mask Requirement, With Half Wanting the Mandate Extended and the Other Half Wanting to Let it…
 
 
ODI [Overseas Development Institute] [to 09 Apr 2022]
https://odi.org/en/publications/
Publications
Monitoring G20 contributions to global Covid-19 vaccine equity: issues and options
28 March 2022
Briefing/policy papers
Key messages
A focus on the systematic monitoring of G20 country policy responses to Covid-19 facilitates better understanding of the extent to which they have supported health equity globally and where they fall short and highlights actions G20 countries can take to place equity at the front and centre of recovery efforts.
Any efforts to construct a composite index must consider carefully how to treat the indicators, weight indicators and dimensions, and aggregate the data; the brief outlines options and their implications.
Efforts to monitor G20’s Covid-19 response are beset by limitations, not least the absence of indicators on actions no member country has taken, such as compelling pharmaceutical companies to share vaccines, knowledge and patents with poorer countries.
The available data reveals huge variation in G20 country performance, irrespective of their incomes, and between what countries have done and what they could have done to advance equity.
 
 
Rand [to 09 Apr 2022]
https://www.rand.org/pubs.html
Reports, Selected Journal Articles
[No new digest content identified]

Vaccines and Global Health: The Week in Review :: 2 April 2022

Posted on by

Vaccines and Global Health: The Week in Review is a weekly digest  summarizing news, events, announcements, peer-reviewed articles and research in the global vaccine ethics and policy space. Content is aggregated from key governmental, NGO, international organization and industry sources, key peer-reviewed journals, and other media channels. This summary proceeds from the broad base of themes and issues monitored by the Center for Vaccine Ethics & Policy in its work: it is not intended to be exhaustive in its coverage. You are viewing the blog version of our weekly digest, typically comprised of between 30 and 40 posts below all dated with the current issue date

.– Request an Email Summary: Vaccines and Global Health : The Week in Review is published as a single email summary, scheduled for release each Saturday evening before midnight (EDT in the U.S.). If you would like to receive the email version, please send your request to david.r.curry@centerforvaccineethicsandpolicy.org.

– pdf version:  A pdf of the current issue is available here:

vaccines-and-global-health_the-week-in-review_02-april-2022Download

– blog edition: comprised of the approx. 35+ entries posted below.

– Twitter:  Readers can also follow developments on twitter: @vaxethicspolicy.
.
– Links:  We endeavor to test each link as we incorporate it into any post, but recognize that some links may become “stale” as publications and websites reorganize content over time. We apologize in advance for any links that may not be operative. We believe the contextual information in a given post should allow retrieval, but please contact us as above for assistance if necessary.

Support this knowledge-sharing service: Your financial support helps us cover our costs and to address a current shortfall in our annual operating budget. Click here to donate and thank you in advance for your contribution.

.
David R. Curry, MS
Executive Director
Center for Vaccine Ethics and Policy